Aspen Grove Capital’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,630
Closed -$311K 223
2026
Q1
$311K Buy
2,630
+74
+3% +$9.15K 0.06% 135
2025
Q4
$322K Sell
2,556
-29
-1% -$3.78K 0.06% 133
2025
Q3
$378K Sell
2,585
-119
-4% -$18K 0.06% 117
2025
Q2
$422K Buy
2,704
+89
+3% +$14.1K 0.07% 131
2025
Q1
$431K Buy
2,615
+31
+1% +$5.16K 0.08% 123
2024
Q4
$421K Buy
2,584
+20
+0.8% +$3.58K 0.09% 117
2024
Q3
$501K Sell
2,564
-4
-0.2% -$737 0.11% 98
2024
Q2
$445K Sell
2,568
-10
-0.4% -$1.66K 0.1% 112
2024
Q1
$436K Sell
2,578
-1,444
-36% -$270K 0.12% 104
2023
Q4
$792K Buy
4,022
+29
+0.7% +$5.13K 0.24% 71
2023
Q3
$695K Sell
3,993
-6,472
-62% -$1.18M 0.26% 69
2023
Q2
$1.8M Hold
10,465
0.58% 35
2023
Q1
$1.74M Buy
10,465
+127
+1% +$20.8K 0.76% 29
2022
Q4
$1.52M Buy
+10,338
New +$1.53M 0.7% 35

Other funds holding ZTS

Aspen Grove Capital's ZTS Position: Q2 2026 in Review

Aspen Grove Capital sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,630 shares — an estimated $311K sold.

Aspen Grove Capital first reported a position in ZTS in Q4 2022 and held it in 14 quarters. The position peaked at $1.8M in Q2 2023. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Aspen Grove Capital reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Aspen Grove Capital sold 2,630 Zoetis shares in Q2 2026, an estimated $311K.
  • Aspen Grove Capital first reported a position in Zoetis in Q4 2022 and held it in 14 quarters.
  • Aspen Grove Capital's Zoetis position peaked at $1.8M in Q2 2023.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.